Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PET TDM FDG-Choline as a Decision-making Tool for Routine Care on Inclusion on the Liver Transplant List for Hepatocellular Carcinoma

NCT04792801 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04792801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04792801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PET TDM FDG-Choline as a Decision-making Tool for Routine Care on Inclusion on the Liver Transplant List for Hepatocellular Carcinoma
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Active, not recruiting
Start date
June 22, 2021
Completion date
June 5, 2028
Enrollment
108 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver transplant